Nutrient control of phosphorylation and translocation of Foxo1 in C57BL/6 and db/db mice

International Journal of Molecular Medicine

Volumn 18, Issue 3, 2006, Pages 433-439

  Aoyama, Hisanori ^a   Daitoku, Hiroaki ^a   Fukamizu, Akiyoshi ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

db db mice; Diabetes; Foxo1; Nutrient; Phosphorylation; Translocation

Indexed keywords

CREB1 PROTEIN, MOUSE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; FORKHEAD TRANSCRIPTION FACTOR; FOXO1 PROTEIN, MOUSE; ONCOPROTEIN;

ANIMAL; ARTICLE; C57BL MOUSE; COMPARATIVE STUDY; DIET; EXPERIMENTAL DIABETES MELLITUS; GENETIC TRANSCRIPTION; METABOLISM; MOUSE; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN TRANSPORT; TISSUE DISTRIBUTION; TRANSACTIVATION;

ANIMALS; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DIABETES MELLITUS, EXPERIMENTAL; DIET; FORKHEAD TRANSCRIPTION FACTORS; MICE; MICE, INBRED C57BL; ONCOGENE PROTEIN V-AKT; PHOSPHORYLATION; PROTEIN TRANSPORT; TISSUE DISTRIBUTION; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC;

EID: 33750588944     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.18.3.433     Document Type: Article

References (38)

1. Nordlie RC, Foster JD and Lange AJ: Regulation of glucose production by the liver. Annu Rev Nutr 19: 379-406, 1999.
2. Staehr P, Hother-Nielsen O and Beck-Nielsen H: Hepatic glucose production: therapeutic target in type 2 diabetes? Diabetes Obes Metab 4: 215-223, 2002.
3. Schmoll D, Walker KS, Alessi DR, Grempler R, Burchell A, Guo S, Walther R and Unterman TG: Regulation of glucose-6- phosphatase gene expression by protein kinase Balpha and the forkhead transcription factor FKHR. Evidence for insulin response unit-dependent and -independent effects of insulin on promoter activity. J Biol Chem 275: 36324-36333, 2000.
4. Nakae J, Kitamura T, Silver DL and Accili D: The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression. J Clin Invest 108: 1359-1367, 2001. (Pubitemid 33107764)
5. Hall RK, Yamasaki T, Kucera T, Waltner-Law M, O'Brien R and Granner DK: Regulation of phosphoenolpyruvate carboxykinase and insulin-like growth factor-binding protein-1 gene expression by insulin. The role of winged helix/forkhead proteins. J Biol Chem 275: 30169-30175, 2000.
6. Puigserver P, Rhee J, Donovan J, Walkey CJ, Yoon JC, Oriente F, Kitamura Y, Altomonte J, Dong H, Accili D and Spiegelman BM: Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1 alpha interaction. Nature 423: 550-555, 2003. (Pubitemid 36648580)
7. Daitoku H, Yamagata K, Matsuzaki H, Hatta M and Fukamizu A: Regulation of PGC-1 promoter activity by protein kinase B and the forkhead transcription factor FKHR. Diabetes 52: 642-649, 2003.
8. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J and Greenberg ME: Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96: 857-868, 1999.
9. Nakae J, Barr V and Accili D: Differential regulation of gene expression by insulin and IGF-1 receptors correlates with phosphorylation of a single amino acid residue in the forkhead transcription factor FKHR. EMBO J 19: 989-996, 2000.
10. Van der Heide LP, Hoekman MF and Smidt MP: The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation. Biochem J 380: 297-309, 2004.
11. Huang H, Regan KM, Wang F, Wang D, Smith DI, van Deursen JM and Tindall DJ: Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation. Proc Natl Acad Sci USA 102: 1649-1654, 2005. (Pubitemid 40209222)
12. Matsuzaki H, Daitoku H, Hatta M, Tanaka K and Fukamizu A: Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation. Proc Natl Acad Sci USA 100: 11285-11290, 2003.
13. Plas DR and Thompson CB: Akt activation promotes degradation of tuberin and FOXO3a via the proteasome. J Biol Chem 278: 12361-12366, 2003.
14. Aoki M, Jiang H and Vogt PK: Proteasomal degradation of the FoxO1 transcriptional regulator in cells transformed by the P3k and Akt oncoproteins. Proc Natl Acad Sci USA 101: 13613-13617, 2004.
15. Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y, Tran H, Ross SE, Mostoslavsky R, Cohen HY, Hu LS, Cheng HL, Jedrychowski MP, Gygi SP, Sinclair DA, Alt FW and Greenberg ME: Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303: 2011-2015, 2004.
16. Motta MC, Divecha N, Lemieux M, Kamel C, Chen D, Gu W, Bultsma Y, McBurney M and Guarente L: Mammalian SIRT1 represses forkhead transcription factors. Cell 116: 551-563, 2004. (Pubitemid 38264432)
17. Accili D and Arden KC: FoxOs at the crossroads of cellular metabolism, differentiation and transformation. Cell 117: 421-426, 2004.
18. Frescas D, Valenti L and Accili D: Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genes. J Biol Chem 280: 20589-20595, 2005.
19. Giannakou ME and Partridge L: The interaction between FOXO and SIRT1: tipping the balance towards survival. Trends Cell Biol 14: 408-412, 2004.
20. Daitoku H, Hatta M, Matsuzaki H, Aratani S, Ohshima T, Miyagishi M, Nakajima T and Fukamizu A: Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity. Proc Natl Acad Sci USA 101: 10042-10047, 2004.
21. Matsuzaki H, Daitoku H, Hatta M, Aoyama H, Yoshimochi K and Fukamizu A: Acetylation of Foxo1 alters its DNA-binding ability and sensitivity to phosphorylation. Proc Natl Acad Sci USA 102: 11278-11283, 2005. (Pubitemid 41153811)
22. Nakae J, Biggs WH III, Kitamura T, Cavenee WK, Wright CV, Arden KC and Accili D: Regulation of insulin action and pancreatic beta-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1. Nat Genet 32: 245-253, 2002.
23. Altomonte J, Richter A, Harbaran S, Suriawinata J, Nakae J, Thung SN, Meseck M, Accili D and Dong H: Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice. Am J Physiol Endocrinol Metab 285: E718-E728, 2003.
24. Barthel A, Schmoll D and Unterman TG: FoxO proteins in insulin action and metabolism. Trends Endocrinol Metab 16: 183-189, 2005.
25. Ye H, Holterman AX, Yoo KW, Franks RR and Costa RH: Premature expression of the winged helix transcription factor HFH-11B in regenerating mouse liver accelerates hepatocyte entry into S phase. Mol Cell Biol 19: 8570-8580, 1999.
26. Cederberg A, Gronning LM, Ahren B, Tasken K, Carlsson P and Enerback S: FOXC2 is a winged helix gene that counteracts obesity, hypertriglyceridemia, and diet-induced insulin resistance. Cell 106: 563-573, 2001. (Pubitemid 32879318)
27. Yamagata K, Daitoku H, Shimamoto Y, Matsuzaki H, Hirota K, Ishida J and Fukamizu A: Bile acids regulate gluconeogenic gene expression via small heterodimer partner-mediated repression of hepatocyte nuclear factor 4 and Foxo1. J Biol Chem 279: 23158-23165, 2004.
28. Kamei Y, Miura S, Suzuki M, Kai Y, Mizukami J, Taniguchi T, Mochida K, Hata T, Matsuda J, Aburatani H, Nishino I and Ezaki O: Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch/red muscle) fiber genes and impaired glycemic control. J Biol Chem 279: 41114-41123, 2004.
29. Herzig S, Long F, Jhala US, Hedrick S, Quinn R, Bauer A, Rudolph D, Schutz G, Yoon C, Puigserver P, Spiegelman B and Montminy M: CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 413: 179-183, 2001. (Pubitemid 32867880)
30. Shimano H: Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes. Prog Lipid Res 40: 439-452, 2001.
31. Ide T, Shimano H, Yahagi N, Matsuzaka T, Nakakuki M, Yamamoto T, Nakagawa Y, Takahashi A, Suzuki H, Sone H, Toyoshima H, Fukamizu A and Yamada N: SREBPs suppress IRS-2-mediated insulin signalling in the liver. Nat Cell Biol 6: 351-357, 2004.
32. Shao J, Yamashita H, Qiao L and Friedman JE: Decreased Akt kinase activity and insulin resistance in C57BL/KsJ-Leprdb/db mice. J Endocrinol 167: 107-115, 2000.
33. Yasukawa T, Tokunaga E, Ota H, Sugita H, Martyn JA and Kaneki M: S-nitrosylation-dependent inactivation of Akt/protein kinase B in insulin resistance. J Biol Chem 280: 7511-7518, 2005.
34. Clodfelder-Miller B, De Sarno P, Zmijewska AA, Song L and Jope RS: Physiological and pathological changes in glucose regulate brain Akt and glycogen synthase kinase-3. J Biol Chem 280: 39723-39731, 2005.
35. Essers MA, Weijzen S, De Vries-Smits AM, Saarloos I, De Ruiter ND, Bos JL and Burgering BM: FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. EMBO J 23: 4802-4812, 2004.
36. Bennett BL, Satoh Y and Lewis AJ: JNK: a new therapeutic target for diabetes. Curr Opin Pharmacol 3: 420-425, 2003.
37. Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, Maeda K, Karin M and Hotamisligil GS: A central role for JNK in obesity and insulin resistance. Nature 420: 333-336, 2002.
38. Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM and Puigserver P: Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 434: 113-118, 2005.